These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 27528036
21. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling. Zhu Z, Hou Q, Guo H. Exp Cell Res; 2020 Dec 01; 397(1):112311. PubMed ID: 32991874 [Abstract] [Full Text] [Related]
25. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer. Rajitha B, Nagaraju GP, Shaib WL, Alese OB, Snyder JP, Shoji M, Pattnaik S, Alam A, El-Rayes BF. Mol Carcinog; 2017 Jan 01; 56(1):288-299. PubMed ID: 27128654 [Abstract] [Full Text] [Related]
26. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. J Exp Clin Cancer Res; 2019 Apr 12; 38(1):159. PubMed ID: 30979374 [Abstract] [Full Text] [Related]
27. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA. Gastroenterology; 2016 Mar 12; 150(3):659-671.e16. PubMed ID: 26619963 [Abstract] [Full Text] [Related]
28. NIT1 suppresses tumour proliferation by activating the TGFβ1-Smad2/3 signalling pathway in colorectal cancer. Lin C, Zhang J, Lu Y, Li X, Zhang W, Zhang W, Lin W, Zheng L, Li X. Cell Death Dis; 2018 Feb 15; 9(3):263. PubMed ID: 29449642 [Abstract] [Full Text] [Related]
29. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK. Voorneveld PW, Kodach LL, Jacobs RJ, Liv N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW, Hommes DW, de Rooij K, van Noesel CJ, Morreau H, van Wezel T, Offerhaus GJ, van den Brink GR, Peppelenbosch MP, Ten Dijke P, Hardwick JC. Gastroenterology; 2014 Jul 15; 147(1):196-208.e13. PubMed ID: 24704720 [Abstract] [Full Text] [Related]
35. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y, Kawada K, Fujishita T, Kakizaki F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa S, Maekawa T, Uemoto S, Sakai Y, Taketo MM. Gastroenterology; 2013 Nov 15; 145(5):1064-1075.e11. PubMed ID: 23891973 [Abstract] [Full Text] [Related]
37. Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis. Mar AC, Chu CH, Lee HJ, Chien CW, Cheng JJ, Yang SH, Jiang JK, Lee TC. J Biol Chem; 2015 Sep 04; 290(36):22212-24. PubMed ID: 26209639 [Abstract] [Full Text] [Related]
38. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. Int J Oncol; 2012 May 04; 40(5):1501-14. PubMed ID: 22200632 [Abstract] [Full Text] [Related]